Adam JMF. 2006. Obesitas, Pengertian dan Kriteria Diagnosis. Di dalam: Adam JMF, editor. Obesitas dan Sindroma Metabolik. Bandung: Penerbit ALFABETA.
Adriansjah H dan Adam JMF. 2006. Sindroma Metabolik: Pengertian, epidemiologi dan kriteria diagnosis. Di dalam: Adam JMF, editor. Obesitas dan Sindroma Metabolik. Bandung: Penerbit ALFABETA. Adedayo AD, Tijani AA, Musa AA, and Adeniyi TD. 2011. Histological study of
smoke extract of Tobacco nicotiana on the heart, liver, lungs, kidney, and testes of male Sprague-Dawley rats. Niger Med J 52(4): 217–222.
Almatsier S. 2003. Prinsip Dasar Ilmu Gizi. Jakarta: PT Gramedia Pustaka Utama Arendash GW, Sanberg PR, Sengstock GJ. 1995. Nicotine enhances the learning
and memory of aged rats. Pharmacol Biochem Behav 52: 517-523. Balfour D, Benowitz N, Fagerstrom K, Kunze M, and Keil U. 2000. Diagnosis
and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report. Eur Heart J 21: 438-445
Bennet BT, Abee CR, Henrickson R. 1995. Nonhuman Primates in Biomedical Research. Academic Press.
Benowitz NL, Jacob P 3rd, Jones RT, and Rosenberg J. 1982. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 221:368–372.
Benowitz NL. 1986. Clinical pharmacology of nicotine. Annu Rev Med 37: 21-32. Benowitz NL 1990 Clinical pharmacology of inhaled drugs of abuse:
implications in understanding nicotine dependence. NIDA Res Monogr 99:12–29.
Benowitz NL, Jacob P 3rd, Denaro C, and Jenkins R. 1991. Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Ther 49:270–277. Benowitz NL and Jacob P 3rd. 1994. Metabolism of nicotine to cotinine studied
by a dual stable isotope method. Clin Pharmacol Ther 56:483–493.
Benowitz NL. 1996. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18:188–204.
Benowitz NL, Hansson A and Jacob P III. 2002.Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension 39:1107-12
55
Borowitz JL and Isom JE. 2008. Toxicologica l Highlight: Nicotine and tipe 2 diabetes. Toxicol Sci 103(2):225-227
Brandange S and Lindblom L. 1979. Synthesis, structure and stability of nicotine - 1(5) iminium ion, an intermediary metabolite of nicotine. Acta Chem Scand B 33:187–191
Cashman JR, Park SB, Yang ZC, Wrighton SA, Jacob P III, and Benowitz NL. 1992. Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N-oxide. Chem Res Toxicol 5:639–646.
Chen Y, Ohtoh H, Yoshida T. 2000. Middle Age Onset of Obesity in Laboratory- reared Female Cynomolgus Monkey. J Growth 39:53-58.
Cheville NF. 1999. Introduction to Veterinary Pathology. Edisi 2. Iowa: Iowa State University Press.
Chowdhury P, Hosotani R, Chang L, Rayford PL. 1989. Inhibition of CCK or carbachol stimulted amylase release by nicotine. Life Sci 45:2163-2168. Chowdhury P, Hosotani R, Chang L, Rayford PL. 1990. Metabolic and pathologic
effects of nicotine on gastrointestinal tractand pancreas of rats. Pancreas 5:222-229.
Chowdhury P, Udupa KB. 2006. Nicotine as mitogenic stimulus for pancreatic acinar cell proliferation. World J Gastroenterol 12(46):7428-7432.
Collazo-Clavell M. 2011. Question: Is hiperinsulinemia a form of diabetes? http://www.mayoclinic.com/diabetes [terhubung berkala][28 Mei 2012]
Colville T, and Bassert JM. 2002. Clinical Anatomy and Physiology for Veterinary Technicians. Mosby Inc., Missouri.USA
Cuming JL. 2003. Reversible dementia. JAMA 234: 2434-2459.
Cunningham JG and Klein BG. 2007. Texbook of Veterinary Physiology. 4thEd. St. Louis, Missouri: Saunders-Elsevier.
Dempsey D, Tutka P, Jacob P 3rd, Allen F, Schoedel K, Tyndale RF, and Benowitz NL. 2004. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 76:64–72.
Dhurandhar NV. 2001. Infectobesity: Obesity of Infectious Origin. J Nutr 131: 2794S–2797S.
Dhurandhar NV, Whigham LD, Abbott DH, Schultz-darken NJ, Israel BA, Bradley SM, Kemnitz JW, Allison DB. 2002. Human Adenovirus Ad- 36 Promotes Weight Gain in Male Rhesus and Marmoset Monkeys. J Nutr 132 (10): 3155–3160
56
Dugi K. 2006. Diabetes mellitus. http://www.scienceinschool.org/ [3 Juli 2012] Dyce KM, Sack WO and Wensing CJG. 1996. Texbook of Veterinary Anatomy.
2nd ed. Philadelphia:WB Sounders Company.pp. 99-150.
Fant RV, Owen LL, Henningfield JE. 1999. Nicotine Replacement Therapy. Prim Care. 26(3):633-52.
Fenster CP, Rains MF, Noerager B, Quick MW and Lester RAJ. 1997 Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 17: 5747 5759. Frandson RD. 1993. Anatomi dan Fisiologi Ternak. Yogyakarta: Gajah Mada
University Pr.
Fortman DJ, Hewett TA, Bennet BT. 2002. The Laboratory Nonhuman Primate. Florida: CRCPr.
Gamieldien K and Maritz GS. 2004. Postnatal expression of cytochrome P450 1A1, 2A3, and 2B1 mRNA in neonatal rat lung: influence of maternal nicotine exposure. Exp Lung Res 30:121-33
Gonzalez AA, Farre R and Clave P. 2004. Different responsiveness of excitatory and inhibitory enteric motor neurons in the human esophagus to electrical field stimulation and to nicotine. Am J Physiol Gastrointest Liver Physiol. 287:299-306
Gorrod JW and Hibberd AR. 1982. The metabolism of nicotine-delta 1(5)- iminium ion, in vivo and in vitro. Eur J Drug Metab Pharmacokinet 7:293–298.
Grunberg NE, Bowen DJ, Morse DE. 1984. Effects of nicotine on body weight and food consumption in rats. Psychopharmacology 83: 93–98.
Guyton AC. 1996. Fisiologi manusia dan mekanisme penyakit. Andrianto P, Penerjemah; Jakarta: EGC. Terjemahan dari: Human physiology and Mechanism of Disease.
Hamaguchi K, Utsunomiya N, Takaki R, Yoshimatsu H, Sakata T. 2003. Cellular interaction between mouse pancreatic alpha-cell and beta-cell lines: possible contact-dependent inhibition of insulin secretion. Exp Biol Med 228: 1227-1233.
Hancock AS, Du A, Liu J, Miller M, May CL. 2010. Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice. Mol Endocrinol 24(8):1605-14
Harishankar N, Kumar PU, Sesikeran B, Giridharan N. 2011. Obesity Associated patophysiological & histologcal changes in WNIN obese mutant rats. Indian J Med Res 134: 330-340.
57
Hossein A. 2011. The effect of nicotine on the serum level of insulin in adult male Wistar rats. J Cell Anim Biol 5(10):215-218
Howard TD, Shuk-Mei H, Li Z, Jing C, Wei C, Slager R, Gray S, Hawkin GA, Medvedovic M and Wagner JD. 2011. Epigenetic changes with dietary soy in cynomolgus monkey. Plos One 6(10):e26791
Hsu, SM, Raine, L and Fanger, H. 1981. The use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580.
Hukkanen M C, Jacob P, Benowitz N L. 2005. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 57:79-115.
Iguchi A, Gotoh M, Matsunaga H, Yatomi A, Honmura A, Yanase M, Sakamoto N. 1986. Mechanism of central hyperglycemic effect of cholinergic agonists in fasted rats. Am J Physiol 251: 1-7.
Imei J, Ayoshimoto O and Hideki K. 2009. Indentification of a Novel Mechanism
Regulating β-cell Mass: Neuronal relay from the liver to pancreas β-cells.
Islet 1 (1):75-77.
[IPCS INCHEM] International Program for Chemical Safety INCHM. 1991. http://www.inchem.org/documents/pims/chemical/nicotine.htm [Journal online], access:3 February 2009
Jacob P III, Ulgen M, and Gorrod JW. 1997. Metabolism of (-)-(S)-nicotine by guinea pig and rat brain: identification of cotinine. Eur J Drug Metab Pharmacokinet 22:391–394.
Karlsson S, Ahrén B. 1998. Insulin and glucagon secretion by ganglionic nicotinic activation in adrenalectomized mice. Eur J Pharmacol 342: 291-295. Kavanagh K, Fairbanks LA, Bailey, JN, Jorgensen MJ, Wilson M, Zhang L,
Rudel LL, Wagner JD. 2007. Characterization and heritability of obesity and associated risk factors in vervet monkeys. Obesity (15): 1666-1674. Kaufman D, Banerji MA, Shorman I, Smith ELP, Coplan JD, Rosenblum LA,
Kral JG. 2007. Early-Life Stress and the Development of Obesity and Insulin Resistance in Juvenie Bonnet Macaques. J. Diabetes. 56:1382- 1386.
Kyerematen GA, Owens GF, Chattopadhyay B, deBethizy JD, Vesell ES.1988. Sexual dimorphism of nicotine metabolism and distribution in the rat: studies in vivo and in vitro. Drug Metab Dispos 16:823–828.
Kyerematen GA, Vesell ES. 1991. Metabolism of nicotine. Drug Metab Rev 23:3–41.
58
Liu, RH, Mizuta, M and Matsukura S. 2003. Long-term oral nicotine administration reduces insulin resistance in obese rats. Eur J Pharmacol. 458:227-34
Maes HH, Neale MC, Eaves LJ. 1977. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27:325–351. Mahajoeno E. 2000. Toksisitas Ekstrak Tembakau Sisa Pabrik Rokok terhadap
Lalat Rumah (Musca domestica, L). BioSmart 2(2):1-7.
Malfertheiner P, Schutte K. Smoking-a trigger for chronic. 2006. Inflammation and cancer development in the pancreas. Am J Gastroenterol 2006; 101: 160-162
Medina J, Fernández-Salazar LI, García-Buey L, Moreno-Otero R. 2004. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 27 (8): 2057–66.
Miksys S, Hoffmann E and Tyndale R F. 2000. Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment. Biochem Pharmacol 59:1501-11
Mitrou P, Raptis SA, Dimitriadis G. 2010. Insulin action in hyperthyroidism: a focus on muscle and adipose tissue. Endocr Rev. 31(5):663-79.
Morgan TM, Crawford L, Stoller A, Toth D, Yeo KT, Baron JA. 2004. Acute effects of nicotine on serum glucose insulin growth hormone and cortisol in healthy smokers. Metabolism 53: 578-582.
Murphy PJ. 1973. Enzymatic oxidation of nicotine to nicotine 1(5) iminium ion. A newly discovered intermediate in the metabolism of nicotine. J Biol Chem 248:2796–2800.
Napier JR and Napier PH. 1985. The Natural History of the Primate. Cambridge- Massachussets: The MIT Press.
Peterson LA, Trevor A, and Castagnoli N Jr. 1987. Stereochemical studies on thecytochrome P-450 catalyzed oxidation of (S)-nicotine to the (S)- nicotine delta 1(5)-iminium species. J Med Chem 30:249–254.
Pribadi AG. 2008. Mencit dan Tikus sebagai Hewan Model Penelitian Nikotin. [Skripsi].Bogor: Fakultas Peternakan, Institut Pertanian Bogor.
Racette SB, Deusinger SS, Deusinger RH. 2003. Obesity : overview of prevalence, ethiology, and treatment. Phys Ther 83 : 276-288.
59
Rachmat M, Nuryanti S. 2009. Dinamika Agribisnis Tembakau Dunia dan Implikasinya bagi Indonesia. Forum Penelti Agroindustri. 27(2):73-91 Rasband W. 2006. ImageJ for microscopy. Research Services Branch, National
Institute of Mental Health, Bethesda, Maryland, USA. http://rsb.info.nih.gov/ij/ [20 Mei 2012]
Rastogi SC. 2007. Essential Animal Physiology. 4th Ed. New Delhi: New Age International (P) Ltd, Pub.
Reaven GM. 2006. The Metabolic Syndrome: Is this diagnosis necessary? Am J Clin Nutr 83:1237-1247.
Reddy JK and Rao MS. 2006. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290 (5): G852–8.
Rowe N. 1996. The Pictorial Guide to the Living Primates. East Hampton, New York: Pongonias Press.
Roth GS, Mattison JA, Ottinger MA, Chachich ME, Lane MA, Ingram DK. 2004. Aging in rhesus monkeys: relevance to human health intervention. Science 305:1423-1426.
Sajuthi D, Lelana RPA, Iskandriati D, Joeniman B. 1993. Karakteristik Satwa Primata sebagai Hewan Model untuk Penelitian Biomedis. Bogor: Makalah Seminar Sehari Satwa Primata Sebagai Hewan Model dalam Bidang Kedokteran dan Farmasi.
Schoedel KA, Sellers EM, Palmour R, and Tyndale RF. 2003. Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administration. Mol Pharmacol 63:96– 104.
Seaton M, Kyerematen GA, Morgan M, Jeszenka EV, and Vesell ES. 1991. Nicotine metabolism in stumptailed macaques, Macaca arctoides. Drug Metab Dispos 19:946–954.
Sukanto U, Soegondo S, Oemardi M. 1996. Buku Ajar Ilmu Penyakit Dalam. Jakarta: Balai Penerbit FKUI.
Targher G. 2005. How does smoking affect insulin sensitivity?. Diabetes Voice. Special Issue. 50:23-25.
Telford IR and Bridgman CF. 1995. Introduction to Functional Histology 2nd ed. New York: Harper Collins College Publishers. Pp. 309-354.
Urakawa N, Nagata T, Kudo K, Kimura K, and Imamura T. 1994. Simultaneous determination of nicotine and cotinine in various human tissues using capillary gas chromatography/mass spectrometry. Int J Legal Med 106:232–236
60
Valenca SS, Gouveia L, Pimenta W A and Porto L C. 2008. Effect of Oral Nicotine on Rat Liver Stereology. Int J Morphol 26(4):1013-1022.
Wagner JD, Carlson CS, O’Brien TD. 1996. Diabetes mellitus in nonhuman
primates: recent research advances on curent husbandry practice. J Med Primatol 19:609-625.
[WHO] The World Health Organization. 2000. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. Geneva. Di dalam: Adam JMF, editor. Obesitas dan Sindroma Metabolik. Bandung: Penerbit ALFABETA.
[WHO] The World Health Organization. 2006. Prevelence of Obesity.
http://www.who.int/mediacentre/factsheets/fs311/en/index.html. [10 Sep 2007].
[WHO] The World Health Organization. 2007. Diabetes.
http://www.google.com/gwt/n?u=http%3A%2F%2Fwww.who.int%2F [4 Feb2008]
Woods S C, Seeley R J. 2002. Understanding the Physiology of Obesity: review of recent developments in obesity research. Int J Obes Relat Metab Discord 26, Suppl 4: S8-S10.
YanoJK, Mei-Hui Hsu, Keith JG, David SC and Eric FJ.2005. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nature Structural & Molecular Biology 12:822 - 823
Yildiz D. 2004. Nicotine, its metabolism and an overview of its biological effects. Toxicon 43 (2004) 619-632.
Yoshikawa H, Hellström-Lindahl E, Grill V. 2005. Evidence for functional nicotinic receptors on pancreatic beta cells. Metabolism 54: 247-254. Zakariah LMS. 2010. Analisis Hematologi, Nilai Kecernaan dan Tingkah Laku
Monyet Ekor Panjang (Macaca fascicularis) Jantan Obes yang Diintervensi Nikotin. [tesis]. Bogor. Program Pascasarjana Institut Pertanian Bogor.
Zechner R, Strauss JG, Haemmerle G, Lass A, Zimmermann R. 2005. Lipolysis: pathway under construction. Curr OpinLipidol 16, 333-340.
Zimmet P, Alberti KG, Shaw J. 2001. Global and societal implications of the diabetes epidemic. 414: 782-787.
Zins BJ, Sandborn WJ, Mays DC, Lawson GM, McKinney JA, Tremaine WJ, Mahoney DW, Zinsmeister AR, Hurt RD, Offord KP, and Lipsky JJ. 1997. Pharmacokinetics of nicotine tartrate after single-dose liquid enema, oral and intravenous administration. J Clin Pharmacol 37:426–436.
61
62
Lampiran 2 Tabel hasil uji-t kadar glukosa pada kelompok Ob- dan pOb- Glukosa Ob- dan pOb-
Waktu
t-test for Equality of Means
t df nilai-p Beda Rerata Ob- dan pOb- Galat baku beda dua rerata Selang Kepercayaan 95 % Upper Lower 1 1,207 8 0,262 5,800 4,806 -5,283 16,883 2 1,207 8 0,262 5,800 4,806 -5,283 16,883 3 1,207 8 0,262 5,800 4,806 -5,283 16,883 4 1,207 8 0,262 5,800 4,806 -5,283 16,883
Lampiran 3 Tabel hasil uji-t kadar glukosa pada kelompok Ob+ dan pOb+ Glukosa Ob+ dan pOb+
Waktu
t-test for Equality of Means
t df nilai-p Beda Rerata Ob+ dan pOb+ Galat baku beda dua rerata Selang Kepercayaan 95 % Upper Lower 1 -1,396 8 0,200 -19,000 13,612 -50,389 12,389 2 -0,068 8 0,947 -0,400 5,848 -13,886 13,086 3 0,144 8 0,889 1,000 6,922 -14,963 16,963 4 -2,591 8 0,032 -16,400 6,329 -30,995 -1,805
Lampiran 4 Tabel Rataan Jumlah Pulau Langerhans, Area Positif (%) dan Kadar Insulin (µIU/ml) MEP Akhir Penelitian
Peubah Kelompok
pOb+ Ob+ pOb - Ob-
Jml P Langhans 37,2 38 28,8 24,2
Area pos (%) 45,47 50,95 39,86 33,63 Insulin (µIU/ml) 12,34 13,41 37,04 112,9
63
Lampiran 5 Tabel hasil Anova pulau Langerhans pankreas MEP ANOVA
Dependent Variable: P Langerhans Source
Type III Sum of
Squares df Mean Square F Sig.
grup 670,550 3 223,517 0,326 0,807
Error 10.986,400 16 686,650
Total 32.201,000 20
a. R Squared = ,058 (Adjusted R Squared = -,119)
Lampiran 6 Tabel hasil Anova kadar insulin MEP ANOVA
Dependent Variable: Insulin Source
Type III Sum of
Squares df Mean Square F Sig.
Grupi 14.050,826 3 4.683,609 18,606 0,002
Error 1.510,357 6 251,726
Total 32.026,923 10
a. R Squared = ,903 (Adjusted R Squared = ,854)
Lampiran 7 Tabel hasil uji LSD pada kadar insulin kelompok Ob-/Ob+ dan pOb- dan pOb+ MEP selama penelitian
Multiple Comparisons
Dependent Variable: Insulin
(I) Grupi (J) Grupi
Mean
Difference (I-J) Std. Error Sig.
95% Confidence Interval Upper Bound Lower Bound LSD Obneg obpos 86,9767(*) 14,48350 0,001 51,5368 122,4165 pObneg 75,8600(*) 15,86588 0,003 37,0376 114,6824 pObpos 103,5233(*) 14,48350 0,000 68,0835 138,9632 Obpos obneg -86,9767(*) 14,48350 0,001 -122,4165 -51,5368 pObneg -11,1167 14,48350 0,472 -46,5565 24,3232 pObpos 16,5467 12,95444 0,249 -15,1517 48,2450 pObneg obneg -75,8600(*) 15,86588 0,003 -114,6824 -37,0376 obpos 11,1167 14,48350 0,472 -24,3232 46,5565 pObpos 27,6633 14,48350 0,105 -7,7765 63,1032 pObpos obneg -103,5233(*) 14,48350 0,000 -138,9632 -68,0835 obpos -16,5467 12,95444 0,249 -48,2450 15,1517 pObneg -27,6633 14,48350 0,105 -63,1032 7,7765 Based on observed means.